Keenova Therapeutics plc Deferred Compensation Plan Assets
Keenova Therapeutics plc had Deferred Compensation Plan Assets of $37.20 million as of 2024-12-27, per its 10-K filed 2025-03-13.
Financial Statements › Notes › and Other Assets
us-gaap:DeferredCompensationPlanAssets · last filed 2025-03-13
- 2024-12-27: Deferred Compensation Plan Assets $37.20M.
- 2023-12-29: Deferred Compensation Plan Assets $38.00M.
- 2022-12-30: Deferred Compensation Plan Assets $39.50M.
- 2021-12-31: Deferred Compensation Plan Assets $43.40M.
| Period end | Deferred Compensation Plan Assets |
|---|---|
| 2024-12-27 | $37.20M 10-K · filed 2025-03-13 |
| 2023-12-29 | $38.00M 10-K · filed 2025-03-13 |
| 2022-12-30 | $39.50M 10-K · filed 2024-03-26 |
| 2021-12-31 | $43.40M 10-K · filed 2023-03-03 |
| 2020-12-25 | $45.00M 10-K · filed 2022-03-15 |
| 2019-12-27 | $43.80M 10-K · filed 2021-03-10 |
| 2018-12-28 | $58.40M 10-K · filed 2020-02-26 |
| 2017-12-29 | $58.10M 10-K · filed 2019-02-26 |
| 2016-12-30 | $59.90M 10-K · filed 2018-02-27 |
| 2016-09-30 | $59.20M 10-K · filed 2016-11-29 |
| 2015-09-25 | $57.90M 10-K · filed 2016-11-29 |
| 2014-09-26 | $56.30M 10-K · filed 2015-11-24 |
| 2013-09-27 | $54.60M 8-K · filed 2015-04-03 |
| 2012-09-28 | $37.80M 10-K · filed 2013-12-13 |